📖

ABCA1 - ATP-Binding Cassette Transporter A1

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-abca1

Related Entities

Metadata

slug	genes-abca1
entity_type	gene
kg_node_id	abca1

Linked Artifacts (832)

mentions🧪Membrane Cholesterol Gradient Modulators90%

mentions🧫ABCA1 rs2230806 polymorphism association with dementia risk 80%

mentions🧪Membrane Cholesterol Gradient Modulators80%

mentions🔬Investigate how lipid raft composition (cholesterol metaboli70%

mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise70%

mentions🧪LRP1-Dependent Tau Uptake Disruption70%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

see_also🧪Membrane Cholesterol Gradient Modulators70%

mentions🔬Investigate how lipid raft composition (cholesterol metaboli63%

see_also📖Amyloid Beta 40 (Aβ40) - Biomarker60%

see_also📖Amyloid PET Imaging - Diagnostic Biomarker60%

see_also📖Complement Component 3 (C3)60%

see_also📖Neuron-Specific Enolase (NSE) - Biomarker60%

see_also📖p-tau60%

see_also📖Total Tau (t-Tau) - Biomarker60%

see_also📖Tumor Necrosis Factor Alpha (TNF-α) as a Neurodegenerative D60%

see_also📖Aging-Associated Astrocytes60%

see_also📖Aging Microglia60%

see_also📖Aging Oligodendrocytes60%

see_also📖Amyloid-Beta Accumulating Neurons60%

see_also📖Amyloid-Beta Metabolism in Cortical Neurons60%

see_also📖Amyloid-Beta-Exposed Neurons60%

see_also📖amyloid-responsive-microglia60%

see_also📖Astrocytes60%

see_also📖Astrocytes in Amyotrophic Lateral Sclerosis60%

see_also📖Astrocytes in Argyrophilic Grain Disease60%

see_also📖Astrocytes in Hepatic Encephalopathy60%

see_also📖Astrocytes in Brain Homeostasis60%

see_also📖Astrocytes in Neurodegeneration60%

see_also📖Astrocytes in Parkinson's Disease Neurodegeneration60%

see_also📖Astrocytes in Wilson Disease60%

see_also📖Autophagy-Deficient Neurons in Neurodegeneration60%

see_also📖Autophagy-Deficient Neurons60%

see_also📖Autophagy-Impaired Neurons60%

see_also📖Autophagy-Lysosomal Dysfunction Neurons60%

see_also📖Betz Cells in Amyotrophic Lateral Sclerosis60%

see_also📖Astrocytes in Dementia with Lewy Bodies60%

see_also📖Cortical GABAergic Interneurons in Amyotrophic Lateral Scler60%

see_also📖Microglia60%

see_also📖Microglia in Alzheimer's Disease Neurodegeneration60%

see_also📖Microglia in Batten Disease60%

see_also📖Microglia in Huntington's Disease60%

see_also📖Microglia in Chronic Neuroinflammation60%

see_also📖Microglia in Nasu-Hakola Disease60%

see_also📖Microglia in Alzheimer's Disease Neurodegeneration60%

see_also📖Microglia in Neuroinflammation60%

see_also📖Microglia in Parkinson Disease60%

see_also📖Microglia in Rasmussen Encephalitis60%

see_also📖Microglia State Index60%

see_also📖Microglia in Synapse Pruning60%

see_also📖Motor Cortex in Amyotrophic Lateral Sclerosis60%

see_also📖Astrocytes in Neurodegeneration60%

see_also📖Microglia in Parkinson's Disease Substantia Nigra60%

see_also📖Oculomotor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖ATP P2X3 Receptor Neurons60%

see_also📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Spinal Cord Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Tauopathy-Associated Neurons60%

see_also📖Tauopathy Neurons60%

see_also📖Tau Pathology Astrocytes (TPA)60%

see_also📖Upper Motor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Alzheimer Hippocampal Circuit60%

see_also📖amiloride-als60%

see_also📖atl1103-antisense-als60%

see_also📖Creatine ALS Trial60%

see_also📖D-Cycloserine ALS Trial60%

see_also📖Edaravone ALS Trial60%

see_also📖Gabapentin ALS Trial60%

see_also📖Idebenone ALS Trial60%

see_also📖Intravenous Immunoglobulin (IVIG) in ALS Trial60%

see_also📖Lithium Carbonate in Amyotrophic Lateral Sclerosis60%

see_also📖Lithium Continuation in ALS Trial60%

see_also📖Masitinib ALS Trial60%

see_also📖Low-Dose Naltrexone ALS Trial60%

see_also📖nimodipine-als60%

see_also📖Riluzole ALS Trials60%

see_also📖Sargramostim (GM-CSF) ALS Trial60%

see_also📖Sodium Phenylbutyrate ALS Trial60%

see_also📖Tauraso (Nimodipine) ALS Trial60%

see_also📖High-Dose Vitamins ALS Trial60%

see_also📖NeuRon Therapeutics60%

see_also📖tau-pet-4r-tauopathies60%

see_also📖AMPK (AMP-Activated Protein Kinase)60%

see_also📖Amyloid PET Imaging60%

see_also📖Amyloid Precursor Protein (APP)60%

see_also📖Amyloid-Related Imaging Abnormalities (ARIA)60%

see_also📖Astrocytes60%

see_also📖Autophagy60%

see_also📖entities-bace160%

see_also📖Microglia60%

see_also📖Microglia in Neurodegeneration60%

see_also📖MTOR (Redirect)60%

see_also📖PSD-95 (Postsynaptic Density Protein 95)60%

see_also📖Tau Oligomers60%

see_also📖Tau PET Imaging in Neurodegenerative Disease60%

see_also📖entities-tfeb60%

see_also📖entities-tnf60%

see_also📖TREM2 Protein (Triggering Receptor Expressed on Myeloid Cell60%

see_also📖Tumor Necrosis Factor (TNF)60%

see_also📖mTOR Signaling Dysregulation in Progressive Supranuclear Pal60%

see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%

see_also📖Tau Co-Pathology in DLB Clinical Heterogeneity60%

see_also📖Environmental Exposure Causal Attribution in ALS — Experimen60%

see_also📖Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%

see_also📖Sleep and Respiratory Network Interaction in ALS — Experimen60%

see_also📖Tau ASO Therapy60%

see_also📖ALS Trial Failures Knowledge Gap60%

see_also📖Complement System Dysregulation in Neurodegeneration - Resea60%

see_also📖Tau vs TDP-43 Fate Switching in Frontotemporal Dementia60%

see_also📖ABCA2 Gene - ATP Binding Cassette Subfamily A Member 260%

see_also📖ABCG1 Gene60%

see_also📖ACTB Gene60%

see_also📖APOA1 Gene60%

see_also📖APOC1 Gene — Apolipoprotein C-I60%

see_also📖APOC2 Gene60%

see_also📖APOC3 Gene60%

see_also📖apoe60%

see_also📖app60%

see_also📖ATG5 — Autophagy Related 560%

see_also📖bace160%

see_also📖CYP46A1 — Cholesterol 24-Hydroxylase60%

see_also📖eif4ebp160%

see_also📖FASN Gene60%

see_also📖gsk3b60%

see_also📖HDAC3 Gene60%

see_also📖HK260%

see_also📖HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase60%

see_also📖JUN Gene60%

see_also📖MAP1LC3A Gene60%

see_also📖LDLR Gene60%

see_also📖LIPA Gene60%

see_also📖LRP1 Gene60%

see_also📖LRP8 Gene60%

see_also📖MTOR Gene60%

see_also📖NPC2 — NPC Intracellular Cholesterol Transporter 260%

see_also📖P2RY12 Gene60%

see_also📖PI3K — Phosphoinositide 3-Kinase60%

see_also📖SPTLC1 - Serine Palmitoyltransferase60%

see_also📖SQSTM1 — Sequestosome 1 (p62)60%

see_also📖TFEB60%

see_also📖TNF - Tumor Necrosis Factor60%

see_also📖TREM2 — Triggering Receptor Expressed on Myeloid Cells 260%

see_also📖ULK1 — UNC-51 Like Kinase 160%

see_also📖Amyloid plaque and neurofibrillary tangle deposition is an e60%

see_also📖hypotheses-apoe-contributes-alzheimers-disease-regulat60%

see_also📖Tau Pathology Severity Assessment Model — Braak Staging and 60%

see_also📖trem2-alpha-synuclein-clearance-parkinsons60%

see_also📖Autophagy-Proteostasis Dual Activation60%

see_also📖Autophagy-Targeting Chimera (AUTOTAC) Therapy60%

see_also📖LRP1-Targeted ApoE-Mimetic Peptide Delivery60%

see_also📖Microglia-Targeted Nanoparticles for CNS Delivery60%

see_also📖Tau-Seed Interception Using Conformational-Selective Extrace60%

see_also📖Lipophagy Activation Therapy for Neurodegeneration60%

see_also📖Microglia-State Editing via TREM2-LXR Pulse Program60%

see_also📖AMPK Agonist Therapy for Neurodegeneration60%

see_also📖APP Gene Dosage Reduction Therapy for Down Syndrome60%

see_also📖Complement Pathway Inhibition Therapy for Neurodegeneration60%

see_also📖LRP1-Enhanced Perivascular Drainage Therapy60%

see_also📖Microglia-State Editing via TREM2-LXR Pulse Program60%

see_also📖Tau-PROTAC Heterobifunctional Degrader for Tauopathy60%

see_also📖alzheimer-europe60%

see_also📖Alzheimer Indonesia60%

see_also📖Healey Center for ALS60%

see_also📖Packard Center for ALS Research60%

see_also📖Amyloid Therapeutics: Investment Landscape Analysis60%

see_also📖Autophagy and Mitophagy Therapeutics Investment Landscape60%

see_also📖Complement System Therapeutics for Neurodegeneration60%

see_also📖Tau Proteostasis and Clearance Across 4R-Tauopathies60%

see_also📖aging-neurodegeneration60%

see_also📖Aging to AD Switch: Triggers60%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

see_also📖Amyloid-Beta Aggregation and Plaque Formation60%

see_also📖amyloid-beta-cellular-uptake60%

see_also📖Amyloid-beta Cellular Uptake Pathway60%

see_also📖Amyloid-beta Degradation Pathways60%

see_also📖Amyloid-beta Fibril Formation60%

see_also📖Amyloid-beta Fibril Formation Pathway60%

see_also📖amyloid-beta-metalloproteinases60%

see_also📖Amyloid-beta Oligomerization Pathway60%

see_also📖Amyloid-beta Trans-synaptic Spread Pathway60%

see_also📖Amyloid Cascade Pathway60%

see_also📖amyloid-cascade-hypothesis60%

see_also📖amyloid-cascade-pathway60%

see_also📖Amyloid-Beta Clearance Therapeutic Pathways60%

see_also📖Amyloid Conformational Strains60%

see_also📖amyloid-hypothesis60%

see_also📖Amyloid Oligomers in Neurodegeneration60%

see_also📖Amyloid-Tau Synergistic Interaction Hypothesis60%

see_also📖Amyloid-Tau Synergistic Interaction Hypothesis in Alzheimer&60%

see_also📖Amyloid vs Tau-First Hypothesis60%

see_also📖Amyloid vs Tau-First Hypothesis in Alzheimer's Disease60%

see_also📖autophagy60%

see_also📖Autophagy Modulation with Bioactive Compounds for Neurodegen60%

see_also📖Autophagy Dysfunction in Progressive Supranuclear Palsy60%

see_also📖autophagy-lysosomal-ad60%

see_also📖autophagy-lysosomal-alzheimers60%

see_also📖Autophagy-Lysosomal Pathway Dysfunction in Corticobasal Synd60%

see_also📖Autophagy-Lysosomal Dysfunction in Neurodegenerative Disease60%

see_also📖Autophagy-Lysosomal Pathway in Parkinson's Disease60%

see_also📖autophagy-lysosome-dysfunction60%

see_also📖Autophagy-Lysosome Pathway in Neurodegeneration60%

see_also📖Autophagy Mechanisms60%

see_also📖Autophagy Molecular Regulation in Neurodegeneration60%

see_also📖Autophagy Types in Neurodegeneration60%

see_also📖Complement Activation in Corticobasal Degeneration60%

see_also📖Complement and Coagulation Systems in 4R-Tauopathies60%

see_also📖Complement-Mediated Synapse Loss60%

see_also📖Complement System in Neurodegeneration60%

see_also📖Complement System Activation in Neurodegeneration60%

see_also📖Complement System in Neurodegeneration60%

see_also📖Complement System Pathway in Neurodegeneration60%

see_also📖Complement Dysregulation in CBS and 4R Tauopathies60%

see_also📖Epidemic Spreading Model of Tau Pathology60%

see_also📖Epigenetics in Amyotrophic Lateral Sclerosis60%

see_also📖erk-mapk-signaling-neurodegeneration60%

see_also📖Granulovacuolar Bodies: Neuronal Defense Mechanism Against T60%

see_also📖Lipophagy Pathway in Neurodegeneration60%

see_also📖Microglia Activation Mechanism60%

see_also📖Microglia in Corticobasal Degeneration60%

see_also📖Microglia in Frontotemporal Dementia Progression60%

see_also📖Microglia and neuroinflammation in Alzheimer's Disease60%

see_also📖Microglia-Neuron Metabolic Cross-Talk in Neurodegeneration60%

see_also📖mitochondrial-dysfunction-als60%

see_also📖oga-inhibition-tau60%

see_also📖Sphingolipid Metabolism in Neurodegeneration60%

see_also📖Sphingolipid Metabolism Dysregulation in 4R-Tauopathies60%

see_also📖Sphingolipid Metabolism in Neurodegeneration60%

see_also📖Sphingolipid Signaling Pathway in Neurodegeneration60%

see_also📖Tauopathy60%

see_also📖TREM2 Mechanism Hub60%

see_also📖Tumor-Derived Cystatin C Enables Amyloid Clearance60%

see_also📖viral-post-infectious-als60%

see_also📖Tau Consortium60%

see_also📖Proteins60%

see_also📖ApoE (Apolipoprotein E)60%

see_also📖APP Protein60%

see_also📖ATG5 Protein60%

see_also📖bace160%

see_also📖GSK3B (Glycogen Synthase Kinase 3 Beta)60%

see_also📖LC3 Protein60%

see_also📖LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)60%

see_also📖MTOR Protein60%

see_also📖GSK3B Protein** is a protein. This page describes its struct60%

see_also📖p62 - Sequestosome 1 (SQSTM1)60%

see_also📖PERK Protein60%

see_also📖SQSTM1 Protein (p62/Sequestosome-1)60%

see_also📖Tau Protein60%

see_also📖TFEB Protein (Transcription Factor EB)60%

see_also📖TREM2 Protein60%

see_also📖ULK1 Protein60%

see_also📖Advanced Immunotherapy Platforms for Tau60%

see_also📖Amyloid Immunotherapy Vaccines for Alzheimer's Disease60%

see_also📖Autophagy Enhancement for Tauopathy60%

see_also📖Autophagy Enhancers in Neurodegeneration60%

see_also📖Autophagy Enhancers for PD60%

see_also📖Autophagy-Enhancing Therapies60%

see_also📖Autophagy Inducers in Neurodegeneration60%

see_also📖complement-c1q-inhibitor-therapy60%

see_also📖Complement Inhibitor Therapy in Neurodegeneration60%

see_also📖Microglia Depletion and Repopulation Therapy60%

see_also📖Microglia Modulation Therapies60%

see_also📖Microglia Modulation Therapy for Neurodegeneration60%

see_also📖Phage Display and Directed Evolution for Tau Therapeutics60%

see_also📖Neuroinflammation PET Imaging in CBS/PSP60%

see_also📖ABCA7 (Redirect)60%

see_also📖entities-grn60%

see_also📖entities-psen160%

see_also📖SORL1 (Redirect)60%

see_also📖GRN Carrier Resilience: Why Some Mutation Carriers Remain As60%

see_also📖abca760%

see_also📖ABI3 Gene60%

see_also📖ACE Gene60%

see_also📖adam1760%

see_also📖ATXN2 Gene60%

see_also📖bin160%

see_also📖CACNA1A — Calcium Channel Alpha-1A Subunit60%

see_also📖CASP4 Gene60%

see_also📖CD2AP Gene — CD2-Associated Protein60%

see_also📖cd3360%

see_also📖clu60%

see_also📖CR1 Gene — Complement Component 1q Receptor60%

see_also📖CTSB Gene60%

see_also📖CTSD — Cathepsin D60%

see_also📖CTSH Gene60%

see_also📖CYBB — Cytochrome b-245, Beta Polypeptide60%

see_also📖DHCR24 Gene60%

see_also📖DPM2 Gene (Dolichol-Phosphate Mannosyltransferase Subunit 2)60%

see_also📖EED60%

see_also📖FERMT2 Gene60%

see_also📖GNB5 Gene60%

see_also📖GRN — Progranulin60%

see_also📖INPP5D — Inositol Polyphosphate-5-Phosphatase D (SHIP1)60%

see_also📖LILRB2 — Leukocyte Immunoglobulin-Like Receptor B260%

see_also📖LPL — Lipoprotein Lipase60%

see_also📖OPTN — Optineurin60%

see_also📖park760%

see_also📖PICALM — Phosphatidylinositol Binding Clathrin Assembly Prot60%

see_also📖PLCG2 Gene60%

see_also📖PSEN1 — Presenilin 160%

see_also📖PSMB5 Gene60%

see_also📖ptk2b60%

see_also📖SMPD1 Gene - Acid Sphingomyelinase60%

see_also📖SNCA — Alpha-Synuclein60%

see_also📖SORL1 Gene60%

see_also📖SPI1 Gene - PU.160%

see_also📖SREBF2 — Sterol Regulatory Element Binding Transcription Fac60%

see_also📖TBK1 — TANK Binding Kinase 160%

see_also📖TMEM106B — Transmembrane Protein 106B60%

see_also📖TP53 Gene60%

see_also📖TBK1-Mediated Neuroinflammation Hypothesis — Autophagy Failu60%

see_also📖CD33 Modulation Therapy for Neurodegeneration60%

see_also📖TMEM106B Lysosomal Restoration Therapy for Neurodegeneration60%

see_also📖MAPK Signaling Inhibitors: Investment Landscape Analysis60%

see_also📖Neuroinflammation and Microglia Pathway in Alzheimer's 60%

see_also📖Neuroinflammation in Corticobasal Degeneration60%

see_also📖Neuroinflammation in Corticobasal Syndrome60%

see_also📖MAPK Signaling Pathways in Neurodegeneration60%

see_also📖neuroinflammation60%

see_also📖Neuroinflammation in PD60%

see_also📖Ataxin-2 (ATXN2)60%

see_also📖CASP4 Protein60%

see_also📖CD33 (Siglec-3)60%

see_also📖FERMT2 Protein60%

see_also📖Progranulin Protein60%

see_also📖OPTN Protein (Optineurin)60%

see_also📖PARK7 Protein (DJ-1)60%

see_also📖PSEN1 Protein (Presenilin-1)60%

see_also📖SORL1 Protein60%

see_also📖TBK1 Protein60%

see_also📖TMEM106B Protein (Transmembrane Protein 106B)60%

see_also📖TMEM106B60%

see_also📖entities-tlr460%

see_also📖TLR4 Gene60%

see_also📖Toll-Like Receptor 4 (TLR4)60%

see_also📖Neurons in Dentatorubral-Pallidoluysian Atrophy60%

see_also📖Neurons in Lysosomal Storage Disorders with Neurodegeneratio60%

see_also📖Neurogenesis60%

see_also📖Neurons60%

see_also📖Neurons — Cell Type Hierarchy60%

see_also📖Neurons in Normal Pressure Hydrocephalus60%

see_also📖Neurons in Prion Disease60%

see_also📖Neurons in Spinocerebellar Ataxia Type 3 (Machado-Joseph Dis60%

see_also📖Neurons Susceptible to Viral Infection60%

see_also📖Neurons in Wilson Disease60%

see_also📖Neurogenesis60%

see_also📖Neurons60%

see_also📖RELA (NF-κB p65)60%

see_also📖BBB Transcytosis Shuttle for Episodic CNS PROTAC Delivery60%

see_also📖BBB-Transcytosis Shuttle for Episodic CNS PROTAC Delivery60%

see_also📖Actin Cytoskeleton Dynamics in Neurodegeneration60%

see_also📖bbb-transport-mechanisms60%

see_also📖Lysosome Dysfunction in Neurodegeneration60%

see_also📖Neurogenesis Impairment in 4R-Tauopathies60%

see_also📖Neurogenesis Disease Comparison60%

see_also📖Neurogenesis Dysfunction Comparison - Neurodegenerative Dise60%

see_also📖Neurogenesis and Neurodegeneration60%

see_also📖NF-κB p65 Protein60%

see_also📖BBB-Penetrant Antibody Engineering60%

see_also📖Neurogenesis-Targeting Therapies for Neurodegenerative Disea60%

see_also📖FLOT1 Gene60%

see_also📖NCSTN Gene - Nicastrin60%

see_also📖NCSTN Protein60%

see_also📖Astrocyte-Derived Exosomal mRNA Reference Genes for Alzheime60%

see_also📖Hippocampus60%

see_also📖acc-chronic-pain60%

see_also📖Astrocyte Precursor Cells60%

see_also📖Hippocampal CA1 Pyramidal Neurons60%

see_also📖Oligodendrocytes in Multiple System Atrophy60%

see_also📖Oligodendrocytes60%

see_also📖Oligodendrocytes in Adrenoleukodystrophy60%

see_also📖Oligodendrocytes in Multiple System Atrophy60%

see_also📖Oligodendrocytes Myelinating60%

see_also📖Oligodendrocytes in CNS Myelination60%

see_also📖Oligodendrocytes in Neurodegeneration60%

see_also📖Astrocyte-Targeted Parkinson's Disease Therapies60%

see_also📖Astrocyte-Targeted Parkinson's Disease Therapy Companie60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖entities-oligodendrocytes60%

see_also📖Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%

see_also📖astrocyte-neuron-metabolic-coupling-parkinsons60%

see_also📖Astrocyte-Neuron Metabolic Coupling Hypothesis in Parkinson&60%

see_also📖Astrocyte-to-Neuron Reprogramming Therapy60%

see_also📖Astrocyte Glutamate-Buffer Rescue: EAAT2 Transcription Reboo60%

see_also📖Astrocyte Glutamate-Buffer Rescue with EAAT2 Transcription R60%

see_also📖Apoptosis Inhibitors for Neurodegeneration — Investment Land60%

see_also📖Astrocyte Therapeutics for Neurodegeneration: Investment Ana60%

see_also📖Apoptosis Pathway in Neurodegeneration60%

see_also📖Apoptosis Pathways in Alzheimer's Disease60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖Apoptosis Pathways in Parkinson's Disease60%

see_also📖Astrocyte Dysfunction in Parkinson's Disease60%

see_also📖Astrocyte Iron Metabolism and Alpha-Synuclein Pathology in P60%

see_also📖Astrocyte Metabolic Enhancement Therapy for PD60%

see_also📖Astrocyte-Mediated Neuroinflammation60%

see_also📖Astrocyte-Neuron Metabolic Coupling Pathway60%

see_also📖Astrocyte Reactivity Mechanism60%

see_also📖Astrocyte Reactivity in 4R-Tauopathies60%

see_also📖Astrocyte Senescence Pathway in Neurodegeneration60%

see_also📖Astrocyte Metabolic Modulation Therapy for Neurodegeneration60%

see_also📖astrocyte-modulation-therapy60%

see_also📖AT(N) Biomarker Classification for Alzheimer's Disease60%

see_also📖A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di60%

see_also📖Combination Biomarker Panels for Alzheimer's Disease60%

see_also📖Cholinergic Basal Forebrain Neurons in Alzheimer's Dise60%

see_also📖Cortical Layer 5 Pyramidal Neurons in Alzheimer's Disea60%

see_also📖Dentate Gyrus Granule Cells in Alzheimer's Disease60%

see_also📖Disease-Associated Microglia in Alzheimer's Disease60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Early Alzheimer's 60%

see_also📖Entorhinal Cortex Layer II Neurons in Alzheimer's Disea60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Alzheimer Disease60%

see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%

see_also📖Locus Coeruleus Norepinephrine in AD60%

see_also📖Temporal Cortex Neurons in Alzheimer's Disease60%

see_also📖AMDX-2011P Phase 2 Trial for Alzheimer's Disease60%

see_also📖AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Diseas60%

see_also📖Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT062260%

see_also📖Bilingualism Cognitive Reserve AD Trial60%

see_also📖Lactococcus lactis CKDB001 for Alzheimer's Disease (NCT60%

see_also📖LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Dise60%

see_also📖Methylphenidate + iTBS for Apathy in AD (PRIME Trial)60%

see_also📖MK-1167 Phase 2 Alzheimer's Disease Trial60%

see_also📖Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation60%

see_also📖NCT04840979 - Genetic Variants Affecting Microglial Activati60%

see_also📖NCT07138677: MCI Network Guided TMS for Early Alzheimer'60%

see_also📖RO7812653 for Early Symptomatic Alzheimer's Disease60%

see_also📖TTYP01 Phase 2 Alzheimer's Disease Trial60%

see_also📖XTR006 Tau PET for Alzheimer's Disease (NCT07115238)60%

see_also📖Accelerating Medicines Partnership Alzheimer's Disease 60%

see_also📖Neurodegeneration60%

see_also📖Experiment: Autoimmune Hypothesis Testing in AD60%

see_also📖Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%

see_also📖SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%

see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%

see_also📖Cholinergic Hypothesis in Alzheimer's Disease60%

see_also📖Glia-Neuron Crosstalk in Alzheimer's Disease60%

see_also📖Glymphatic System in Alzheimer's Disease60%

see_also📖Infectious Etiology Hypotheses in Alzheimer's Disease60%

see_also📖Infectious Triggers in Alzheimer's Disease60%

see_also📖Innate Immune Signaling Pathways in Alzheimer's Disease60%

see_also📖Integrated Stress Response in Alzheimer's Disease60%

see_also📖Microglial State Trajectory from Mobilization to Dysregulati60%

see_also📖mitochondrial-dysfunction-ad60%

see_also📖Neuronal Death Pathways in Alzheimer's Disease60%

see_also📖PKM2 Metabolic Dysregulation in Alzheimer's Disease60%

see_also📖psilocybin-neuropsychiatric-ad60%

see_also📖RNA Metabolism Dysregulation in Alzheimer's Disease60%

see_also📖Sleep Disruption in Alzheimer's Disease60%

see_also📖Vascular Contributions to Alzheimer's Disease60%

see_also📖Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD)60%

see_also📖CAR-A (Chimeric Antigen Receptor) Astrocyte Therapy for Alzh60%

see_also📖Ferulic Acid Carbamate Derivatives for Alzheimer's Dise60%

see_also📖Ras-MAPK Signaling Pathway in Neurodegeneration60%

see_also📖Epigenetic Biomarkers in Neurodegenerative Diseases60%

see_also📖Cerebellar Granule Cells in Neurodegenerative Disease60%

see_also📖Cerebellar Neurons in Creutzfeldt-Jakob Disease60%

see_also📖Cerebellar Purkinje Cells60%

see_also📖Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Di60%

see_also📖Pedunculopontine Nucleus Neurons in Lewy Body Disease60%

see_also📖Spinal Cord Interneurons in Motor Neuron Disease60%

see_also📖Notch Signaling and Gamma-Secretase Modulators for Alzheimer60%

see_also📖Notch and Gamma-Secretase Modulators for Parkinson's Di60%

see_also📖diseases-motoneuron-disease60%

see_also📖Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%

see_also📖Epigenetic Dysregulation in Huntington's Disease — Ther60%

see_also📖Epigenetic Dysregulation Validation in Parkinson's Dise60%

see_also📖Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%

see_also📖Genes60%

see_also📖AQP4 (Aquaporin-4 Gene)60%

see_also📖ARG1 — Arginase 160%

see_also📖GJA160%

see_also📖NOTCH2 — Notch Receptor 260%

see_also📖YAP1 — Yes-Associated Protein 160%

see_also📖Epigenetic Dysregulation Hypothesis in Parkinson's Dise60%

see_also📖Epigenetic-Metabolic Coupling: SIRT1 Activator + NAD+ Precur60%

see_also📖Epigenetic Clock Reversal Therapy for Neurodegeneration Prev60%

see_also📖Notch Signaling Modulation Therapy for Neurodegeneration60%

see_also📖Epigenetic Therapy in Neurodegeneration: Investment Landscap60%

see_also📖Epigenetic Alterations in Alzheimer's Disease60%

see_also📖Cerebrovascular Disease in Neurodegeneration60%

see_also📖cross-disease60%

see_also📖Epigenetic Alterations in Alzheimer's Disease60%

see_also📖Epigenetic Clocks in Brain Aging60%

see_also📖Epigenetic Dysregulation Comparison Across Neurodegenerative60%

see_also📖Epigenetic Dysregulation in 4R-Tauopathies60%

see_also📖Epigenetic Dysregulation in Neurodegeneration60%

see_also📖Epigenetic Regulation60%

see_also📖Epigenetic Mechanisms in Alzheimer's Disease60%

see_also📖Epigenetic Changes in Progressive Supranuclear Palsy60%

see_also📖IVNS1ABP Mutation: Progeria-Like Disease with Neurological D60%

see_also📖Notch Signaling in Parkinson's Disease60%

see_also📖Notch Signaling in 4R-Tauopathies60%

see_also📖Notch Signaling Pathway in Neurodegeneration60%

see_also📖Notch Signaling in Parkinson's Disease60%

see_also📖Notch Signaling Pathway in Neurodegeneration60%

see_also📖Aquaporin-4 Protein60%

see_also📖GJA1 Protein60%

see_also📖Notch2 Protein60%

see_also📖Epigenetic Reprogramming and Partial Reprogramming in Neurod60%

see_also📖Epigenetic Therapies for Neurodegeneration60%

see_also📖Epigenetic Therapies for Parkinson's Disease60%

see_also📖Notch Signaling Modulators for Neurodegeneration60%

see_also📖Unfolded Protein Response60%

see_also📖Unfolded Protein Response (UPR)60%

see_also📖Cardiac Intrinsic Neurons60%

see_also📖Cardiac MIBG Scan for Parkinsonism60%

see_also📖entities-psen260%

see_also📖entities-sirt160%

see_also📖ABCG4 Gene — ATP-Binding Cassette Subfamily G Member 460%

see_also📖CCR5 Gene60%

see_also📖csf160%

see_also📖KEAP1 — Kelch-Like ECH-Associated Protein 160%

see_also📖PRDX5 — Peroxiredoxin 560%

see_also📖PRKAA160%

see_also📖PSEN2 — Presenilin 260%

see_also📖SIRT1 Gene60%

see_also📖SPTLC2 Gene60%

see_also📖SREBF1 Gene60%

see_also📖TARDBP — TAR DNA Binding Protein 4360%

see_also📖CCR5 Protein60%

see_also📖KEAP1 - Kelch-like ECH-Associated Protein 160%

see_also📖PSEN2 Protein (Presenilin-2)60%

see_also📖tardbp60%

see_also📖mapt60%

related🧪Aquaporin-4 Polarization Rescue55%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread55%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration55%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration55%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration55%

see_also📖Endosomal Sorting Defects in Neurodegeneration55%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration55%

see_also📖PPAR Signaling Pathway in Neurodegeneration55%

see_also📖RNA-Targeted Therapies in Neurodegeneration55%

see_also📖Senescent Cell Clearance in Neurodegeneration55%

mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%

mentions🧪Lysosomal Membrane Repair Enhancement50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Vagal Afferent Microbial Signal Modulation50%

mentions🧪Cross-Seeding Prevention Strategy50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%

mentions🧪APOE-Mediated Synaptic Lipid Raft Stabilization50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪APOE-Mediated Synaptic Lipid Raft Stabilization50%

mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration50%

see_also📖Exosomal Biomarkers in Neurodegeneration50%

see_also📖Exosomal miR-155 in Neurodegeneration50%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration50%

see_also📖Liquid Biopsy in Neurodegeneration50%

see_also📖Metabolomic Biomarkers in Neurodegeneration50%

see_also📖Neuroimaging Biomarkers for Neurodegeneration50%

see_also📖Synaptic Biomarkers in Neurodegeneration50%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and50%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI50%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St50%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451650%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl50%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime50%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 50%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)50%

see_also📖China Neurodegeneration Epidemiology50%

see_also📖DALY Methodology — Neurodegeneration50%

see_also📖Disease Progression & Staging in Neurodegeneration50%

see_also📖Economic Burden — Neurodegeneration50%

see_also📖European Neurodegeneration Epidemiology50%

see_also📖Familial vs Sporadic Neurodegeneration Comparison50%

see_also📖Global Neurodegeneration Epidemiology50%

see_also📖India Neurodegeneration Epidemiology50%

see_also📖Japan Neurodegeneration Epidemiology50%

see_also📖Manganese-Related Neurodegeneration (Manganism)50%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison50%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr50%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 50%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)50%

see_also📖Potential Impact Measures — Neurodegeneration50%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)50%

see_also📖Sleep Disorders in Neurodegeneration50%

see_also📖US Neurodegeneration Epidemiology50%

see_also📖acetylcholine-signaling-neurodegeneration50%

see_also📖Advanced Glycation End Products in Neurodegeneration50%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 50%

see_also📖Amylin Signaling in Neurodegeneration50%

see_also📖Antibody Therapy in Neurodegeneration50%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration50%

see_also📖Autosis Pathway in Neurodegeneration50%

see_also📖Axon Guidance Pathways in Neurodegeneration50%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration50%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain50%

see_also📖CaMKII Signaling Pathway in Neurodegeneration50%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration50%

see_also📖Cholinergic System Dysfunction in Neurodegeneration50%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat50%

see_also📖Neural Circuits in Neurodegeneration50%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration50%

see_also📖Computational Disease Models for Neurodegeneration50%

see_also📖Convergent Pathways in Neurodegeneration50%

see_also📖Copper Homeostasis in Neurodegeneration50%

see_also📖COVID-19 Neurodegeneration Mechanism50%

see_also📖Diffusion MRI (DTI) in Neurodegeneration50%

see_also📖Digital Phenotyping in Neurodegeneration50%

see_also📖Down Syndrome Neurodegeneration Pathway50%

see_also📖Dystrophic Neurites in Neurodegeneration50%

see_also📖Endocannabinoid System in Neurodegeneration50%

see_also📖Endothelin Signaling Pathway in Neurodegeneration50%

see_also📖epigenetics-neurodegeneration50%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration50%

see_also📖FA2H-Associated Neurodegeneration Pathway50%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration50%

see_also📖Galectin-3 Mechanism in Neurodegeneration50%

see_also📖Gangliosides in Neurodegeneration50%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration50%

see_also📖GDNF Signaling Pathway in Neurodegeneration50%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration50%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration50%

see_also📖Glycosylation in Neurodegeneration50%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration50%

see_also📖Hippocampal Neurogenesis in Neurodegeneration50%

see_also📖Histone Modification Pathways in Neurodegeneration50%

see_also📖HMGB1 Signaling in Neurodegeneration50%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration50%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration50%

see_also📖IL-1 Signaling Pathway in Neurodegeneration50%

see_also📖Integrated Stress Response in Neurodegeneration50%

see_also📖interleukin-6-signaling-neurodegeneration50%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration50%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 50%

see_also📖Kidney-Brain Neurodegeneration Axis50%

see_also📖Lipid Dysregulation in Neurodegeneration50%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration50%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration50%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration50%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration50%

see_also📖Metal Homeostasis in Neurodegeneration50%

see_also📖Microglial Priming Pathway in Neurodegeneration50%

see_also📖MicroRNA Dysfunction in Neurodegeneration50%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration50%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration50%

see_also📖Mitochondrial Fusion in Neurodegeneration50%

see_also📖Molecular Chaperones in Neurodegeneration50%

see_also📖mTOR Signaling in Neurodegeneration50%

see_also📖mTOR Signaling Pathway in Neurodegeneration50%

see_also📖Neural Circuit Disruption in Neurodegeneration50%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N50%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati50%

see_also📖Neuronal Hyperexcitability in Neurodegeneration50%

see_also📖Neuropil Threads in Neurodegeneration50%

see_also📖Neurotensin Signaling in Neurodegeneration50%

see_also📖NF-kB Signaling Pathway in Neurodegeneration50%

see_also📖Nitric Oxide Signaling in Neurodegeneration50%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration50%

see_also📖Neuropeptide Y Signaling in Neurodegeneration50%

see_also📖NRF2 Signaling Pathway in Neurodegeneration50%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration50%

see_also📖Orexin Signaling in Neurodegeneration50%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration50%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration50%

see_also📖Paranodal Dysfunction in Neurodegeneration50%

see_also📖Paraptosis in Neurodegeneration50%

see_also📖Parthanatos in Neurodegeneration50%

see_also📖Pericyte Loss in Neurodegeneration50%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration50%

see_also📖PKR Pathway in Neurodegeneration50%

see_also📖Prion Diseases in Neurodegeneration50%

see_also📖Prion-Like Spread in Neurodegeneration50%

see_also📖Prion Protein Metabolism in Neurodegeneration50%

see_also📖Progesterone Signaling Pathway in Neurodegeneration50%

see_also📖Prognostic Biomarkers in Neurodegeneration50%

see_also📖Protein Aggregation Comparison in Neurodegeneration50%

see_also📖Protein Aggregation Seeds in Neurodegeneration50%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration50%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su50%

see_also📖Purinergic Signaling in Neurodegeneration50%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener50%

see_also📖R-Loop Stress in Neurodegeneration50%

see_also📖RAN Translation in Neurodegeneration50%

see_also📖Retinal Degeneration Pathway in Neurodegeneration50%

see_also📖Ribosome Dysfunction in Neurodegeneration50%

see_also📖RNA Splicing in Neurodegeneration50%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a50%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration50%

see_also📖Serotonergic Dysfunction in Neurodegeneration50%

see_also📖Sex Differences in Neurodegeneration50%

see_also📖Short Chain Fatty Acids in Neurodegeneration50%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration50%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration50%

see_also📖Sleep Dysfunction in Neurodegeneration50%

see_also📖SUMOylation in Neurodegeneration50%

see_also📖synaptic-vesicle-cycling-neurodegeneration50%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration50%

see_also📖T-Cell Dysfunction in Neurodegeneration50%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration50%

see_also📖Therapeutic Targets in Neurodegeneration50%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration50%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration50%

see_also📖Vagus Nerve Pathway in Neurodegeneration50%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio50%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio50%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen50%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration50%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE45%

see_also📖APOE4 (Apolipoprotein E4)45%

see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%

see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page45%

see_also📖Alzheimer's Disease Mechanism Index45%

see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%

mentions🔬What are the mechanisms underlying rna binding protein dysre40%

mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction40%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪APOE Isoform Conversion Therapy40%

mentions🔬What are the mechanisms underlying apoe4 structural biology 35%

mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa35%

mentions🔬What are the mechanisms underlying neuroinflammation resolut35%

mentions🔬What are the mechanisms underlying what are the mechanisms b35%

mentions🔬What are the mechanisms underlying mechanistic role of apoe 35%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%

mentions🔬Epigenetic reprogramming in aging neurons35%

mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas35%